Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types

James D Doecke1, Ying Wang2, Keith Baggerly2

  • 1Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA; Commonwealth Scientific and Industrial Research Organization (CSIRO) Health and Biosecurity/Australian E-Health Research Centre, Royal Brisbane and Women's Hospital, Level 5, UQ Health Sciences Building, 901/16, Herston, Queensland 4029, Australia.

Cancer Genetics
|November 5, 2016
PubMed

Insights

Aberrant gene expression in cancer involves DNA methylation and microRNA (miRNA) regulation. This study identified genomic "triplet combinations" linking DNA methylation, miRNA, and mRNA, revealing patterns associated with cancer patient survival.

Area of Science:

  • Genomics
  • Cancer Biology
  • Epigenetics

Background:

  • Aberrant gene expression in cancer is linked to irregular DNA methylation and microRNA (miRNA) target gene downregulation.
  • Understanding these regulatory mechanisms is crucial for cancer research.

Purpose of the Study:

  • To investigate co-localized mRNA, miRNA, and DNA methylation data across 15 cancer types.
  • To identify genomic regulatory patterns associated with cancer outcomes.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) data for 2839 samples.
  • Analyzed correlations (>0.6) between mRNA, miRNA, and DNA methylation probes within co-localized genomic regions.
  • Identified 180 "triplet combinations" indicating co-localized genomic regulation.

Main Results:

  • Identified 32 genes, 34 miRNAs, and 143 DNA methylation sites forming 180 triplet combinations.
  • HOXC5, PDE2A, SH3TC2, and TP63 showed high prevalence of these combinations.
  • Eight genes were significantly associated with survival in Kidney Renal Clear Cell Carcinoma and Low Grade Glioma.

Conclusions:

  • Data support the hypothesis that genes and miRNAs strongly correlated with DNA methylation levels are associated with cancer outcomes.
  • Identified specific regulatory triplets and genes linked to cancer survival, offering potential biomarkers.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs01:22

MicroRNAs

12.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K